STAAR Surgical (STAA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
STAAR Surgical Reports First Quarter 2015 Results
April 29, 2015 4:01 PM EDTMONROVIA, Calif., April 29, 2015 /PRNewswire/ --Â STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2015.
First Quarter Overview
Net Sales of $18.9 Million Decreased 7% from the Year Ago Period and 3% on a Constant Currency Basis ICL Units in North America Increased 18% and EMEA Units Increased 9% CentraFLOW® Accounted for 78% of ICL Shipments in China Gross Margin Increased to 68% in Q1 vs. 57% in Q4 2014... More